A breakthrough study highlights Xenon gas as a potential game-changer in treating Alzheimer’s disease, demonstrating its ...

Researchers report hopeful progress in efforts to find treatments for Alzheimer’s disease. They report a recent clinical ...

The Alzheimer's Association predicts that by 2050 ... while taking advantage of current treatments. "I always say that I think these drugs are a major step forward, but they're not the answer.

Context: Current pharmacologic treatments for Alzheimer's disease (AD) do not prevent long-term clinical deterioration. Tumor necrosis factor (TNF)-alpha, a proinflammatory cytokine, has been ...

This step is important to make sure that only the best and safest treatments are tested on humans in clinical trials. The team examined postmortem brain tissues from Alzheimer's patients using ...

If a diagnosis of Alzheimer's is made, regardless of the severity of the disease, treatment options are available ... placebo controlled studies comparing the effectiveness of the current ...

a timely and accurate diagnosis can improve patients’ chances to benefit from current treatments and participate in clinical trials. We believe accelerating the diagnosis of Alzheimer’s can ...

Blarcamesine is an orally once daily administered small molecule for the potential treatment of patients with Alzheimer’s disease. “The EMA filing acceptance for blarcamesine to review the ...

The Davos Alzheimer’s Collaborative (DAC), a pioneering worldwide initiative seeking to cure Alzheimer’s disease and improve ...

Many lawmakers across the United States and from both sides of the political aisle now agree: Everyone deserves access to treatment for Alzheimer’s disease. Alzheimer’s disease is a terrifying ...

Former study was recently accepted in a peer-reviewed medical journal with focus on Alzheimer’s disease titled, “Blarcamesine for the treatment ... based on current information and ...